P30405 (PPIF_HUMAN) Homo sapiens (Human)

Peptidyl-prolyl cis-trans isomerase F, mitochondrial UniProtKBInterProSTRINGInteractive Modelling

207 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

67 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Scaffold-ligand complex with ligand unmodelled.homo-3-mer44-207
EDO;CIT;
Assess
Crystal structure of cyclophilin D in complex with CsA analogue, JW47.monomer43-207
Assess
0.79A resolution structure of DMSO bound Cyclophilin Dmonomer44-207
DMS;
Assess
0.85A resolution structure of PEG 400 Bound Cyclophilin Dmonomer44-207
PEG;1PE;
Assess
Crystal structure of human cyclophilin D in complex with cyclosporin Amonomer44-207
CIT;
Assess
Human cyclophilin D complexed with dimethylformamidemonomer44-207
DMF;CL;
Assess
Human Cyclophilin D in complex with N-[(5-ethyl-4-oxo-1,2,3,4,5,6- hexahydro-1,5-benzodiazocin-8-yl…monomer44-207
DMS;7UO;
Assess
Human Cyclophilin D Complexed with an Inhibitormonomer44-207
7B7;
Assess
Human Cyclophilin D in complex with N-(5-ethyl-4-oxo-1,2,3,4,5,6-hexahydro-1,5-benzodiazocin-8-yl)-…monomer44-207
VDH;DMS;PG4;
Assess
Human Cyclophilin D Complexed with an Inhibitormonomer44-207
7I6;
Assess
Human Cyclophilin D Complexed with a Fragmentmonomer44-207
4SO;GOL;
Assess
Human Cyclophilin D Complexed with a Fragmentmonomer44-207
MIO;
Assess
Human Cyclophilin D Complexed with a Fragmentmonomer44-207
3AO;
Assess
Human Cyclophilin D in complex with N-(4-aminophenyl)-7-methyl-2-oxo-1H,2H-pyrazolo[1,5-a]pyrimidin…monomer44-207
UX5;DMS;PG4;
Assess
Human cyclophilin D complexed with N-[(4-aminophenyl)sulfonyl]benzamidemonomer44-207
BS4;
Assess
Human Cyclophilin D Complexed with a Fragmentmonomer44-207
1FP;
Assess
Human Cyclophilin D in complex with fragmentmonomer44-207
JVQ;SO4;PGE;PG4;
Assess
Human Cyclophilin D in complex with N-(4-aminophenyl)-7-methyl-2-oxo-1H,2H-pyrazolo[1,5-a]pyrimidin…monomer44-207
V0Z;DMS;
Assess
Human Cyclophilin D Complexed with an Inhibitormonomer44-207
53Z;PO4;
Assess
Human Cyclophilin D in complex with fragmentmonomer44-207
DMS;UPZ;1PE;
Assess
Human Cyclophilin D Complexed with an Inhibitormonomer44-207
728;
Assess
Human Cyclophilin D Complexed with a Fragmentmonomer44-207
FP6;
Assess
Human Cyclophilin D in complex with 1-(((2R,3S,6R)-3-hydroxy-2,3,4,6-tetrahydro-1H-2,6-methanobenzo…monomer44-207
PG4;SO4;PO4;JV2;
Assess
Human Cyclophilin D Complexed with a Fragmentmonomer44-207
MSY;PEG;
Assess
Human Cyclophilin D in complex with 2-(exo-3,5-Dioxo-4-aza-tricyclo[5.2.1.02,6]dec-4-yl)-N-((1R,9R,…monomer44-207
O4B;P6G;JVH;
Assess
Human Cyclophilin D Complexed with Inhibitor.monomer44-207
K;PG4;EDO;PGE;4ZM;
Assess
Human Cyclophilin D Complexed with a Fragmentmonomer44-207
P33;6AI;
Assess
Human cyclophilin D complexed with 5-methyl-1,2-oxazol-3-aminemonomer44-207
M3I;
Assess
1.45A resolution structure of PEG 400 Bound Cyclophilin Dmonomer44-207
1PE;
Assess
Human Cyclophilin D Complexed with an Inhibitor at room temperaturemonomer44-207
7I6;
Assess
Scaffold-ligand complex with ligand unmodelledmonomer44-207
EDO;12P;PO4;NA;
Assess
Human Cyclophilin D Complexed with Inhibitormonomer44-207
4ZL;K;FMT;PG4;EDO;PGE;
Assess
Structure of Cyclophilin D Peptidyl-Prolyl Isomerase Domain bound to Macrocyclic Inhibitor B2monomer44-207
I3X;
Assess
Human Cyclophilin D Complexed with an Inhibitor at room temperaturemonomer44-207
EA4;
Assess
Crystal structure of human cyclophilin D at 1.54 A resolution at room temperaturemonomer44-207
Assess
Human Cyclophilin D in complex with fragmentmonomer44-207
IU0;
Assess
Human Cyclophilin D Complexed with a Fragmentmonomer44-207
P4C;5MZ;
Assess
Human Cyclophilin D Complexed with an Inhibitormonomer44-207
67Z;DMS;
Assess
Human Cyclophilin D in complex with 1-((1S,9S,10S)-10-Hydroxy-12-oxa-8-aza-tricyclo[7.3.1.02,7]trid…monomer44-207
JUZ;
Assess
Crystal structure of human cyclophilin D (CypD) with in complex with the covalently bound Ebselen i…monomer44-207
9JT;
Assess
Human Cyclophilin D in complex with N-cyclopentyl-N'-pyridin-2-ylmethyl-oxalamidemonomer44-207
JW2;
Assess
Human Cyclophilin D Complexed with a Fragmentmonomer44-207
5AO;P4C;
Assess
Crystal structure of human cyclophilin D at 1.7 A resolutionmonomer44-207
Assess
Human Cyclophilin D Complexed with a Fragmentmonomer44-207
NA;N3M;GOL;
Assess
Crystal structure of human cyclophilin D at 1.7 A resolution, DMSO complexmonomer44-207
DMS;
Assess
Structure of Cyclophilin D Peptidyl-Prolyl Isomerase Domain bound to Macrocyclic Inhibitor JOMBtmonomer44-207
I3Q;
Assess
Human cyclophilin D complexed with quinolin-8-aminemonomer44-207
Q8A;
Assess
Human Cyclophilin D Complexed with Inhibitormonomer44-207
K;FMT;PG4;PGE;PEG;4ZZ;
Assess
Human Cyclophilin D Complexed with Inhibitor.monomer44-207
K;FMT;PG4;PGE;4ZO;
Assess
Human Cyclophilin D Complexed with Inhibitormonomer44-207
K;FMT;PG4;PGE;502;
Assess
Human Cyclophilin D Complexed with Inhibitormonomer44-207
K;FMT;PG4;PGE;4ZP;
Assess
Human Cyclophilin D Complexed with Inhibitormonomer44-207
K;FMT;PG4;PGE;4ZT;PEG;
Assess
Human Cyclophilin D Complexed with an Inhibitormonomer44-207
671;
Assess
Human Cyclophilin D Complexed with an Inhibitormonomer44-207
EA4;
Assess
Human Cyclophilin D in complex with norbornane fragment derivativemonomer44-207
JWB;JVQ;PEG;PG4;SO4;
Assess
Human Cyclophilin D in complex with bicyclic fragmentmonomer44-207
JVN;1PE;PG4;SO4;
Assess
Human Cyclophilin D Complexed with an Inhibitormonomer44-207
6B4;
Assess
Human Cyclophilin D Complexed with Inhibitormonomer44-207
C4Y;
Assess
Crystal structure at room temperature of cyclophilin D in complex with an inhibitormonomer44-207
EA4;
Assess
Structure of Cyclophilin D Peptidyl-Prolyl Isomerase Domain bound to Macrocyclic Inhibitor B21monomer45-207
I56;
Assess
Structure of Cyclophilin D Peptidyl-Prolyl Isomerase Domain bound to Macrocyclic Inhibitor A26monomer45-207
I4F;
Assess
Structure of Cyclophilin D Peptidyl-Prolyl Isomerase Domain bound to Macrocyclic Inhibitor B53monomer45-207
I4R;
Assess
Structure of Cyclophilin D Peptidyl-Prolyl Isomerase Domain bound to Macrocyclic Inhibitor B52monomer45-207
I4V;
Assess
Structure of Cyclophilin D Peptidyl-Prolyl Isomerase Domain bound to Macrocyclic Inhibitor B23monomer45-207
I5E;
Assess
Structure of Cyclophilin D Peptidyl-Prolyl Isomerase Domain bound to Macrocyclic Inhibitor B3monomer45-207
I5J;
Assess
Structure of Cyclophilin D Peptidyl-Prolyl Isomerase Domain bound to Macrocyclic Inhibitor B25monomer45-207
I4Z;
Assess
Structure of Cyclophilin D Peptidyl-Prolyl Isomerase Domain bound to Macrocyclic Inhibitor B1monomer45-206
I44;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3rd9.1.Amonomer0.9144-207
MSY;99.39
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 22z6w.1.Amonomer0.7944-146
95.10
Assess